All In Biotech

Free tool

FAERS Monitor: Zestril

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019777 or its brand name (Zestril, Lisinopril). Reports on generic versions are filed under their own applications.

Reports

307,269

Serious

186,997

61% of reports

Hospitalization

98,349

Death reported

25,491

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue20,139
  • nausea18,701
  • drug ineffective17,858
  • diarrhoea17,531
  • dyspnoea14,122
  • pain13,788
  • dizziness13,716
  • headache13,187
  • off label use11,262
  • vomiting11,193
  • asthenia11,051
  • arthralgia9,780
  • acute kidney injury9,626
  • fall9,216
  • chronic kidney disease9,132

Reports by year received

View as table
YearReports
20043,531
20054,429
20064,749
20074,668
20085,695
20097,749
201010,965
201111,262
201213,038
201312,466
201417,956
201522,223
201622,908
201721,645
201823,498
201922,728
202018,102
202115,726
202215,254
202313,279
202412,698
202513,641
20269,056

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,746,890 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
chronic kidney diseaseSignal9,1329.29.059,039
acute kidney injurySignal9,6264.54.424,970
astheniaSignal11,0512.02.05,810
fall9,2161.91.94,019
dizziness13,7161.91.95,896
diarrhoea17,5311.91.97,285
fatigue20,1391.81.87,118
dyspnoea14,1221.71.74,318
vomiting11,1931.61.62,825
nausea18,7011.61.64,647
arthralgia9,7801.61.62,340
pain13,7881.51.52,699
headache13,1871.41.41,852
drug ineffective17,8580.90.9109
off label use11,2620.90.9194

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.